| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | US20010003646 Composition for keeping away vermin |
| 06/14/2001 | US20010003590 Process for manufacturing tablets for the sustained release of active principle(s) |
| 06/14/2001 | US20010003589 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/14/2001 | US20010003588 Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride |
| 06/14/2001 | US20010003585 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2394928A1 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2394580A1 Macrocyclic compounds and their use |
| 06/14/2001 | CA2394303A1 Interferon-alpha induced gene |
| 06/14/2001 | CA2394236A1 Adamantane derivatives |
| 06/14/2001 | CA2394060A1 Transmucosal administration of phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 06/14/2001 | CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/14/2001 | CA2393748A1 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 06/14/2001 | CA2393737A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | CA2393676A1 Therapeutic compositions and methods |
| 06/14/2001 | CA2393601A1 Antiviral medication |
| 06/14/2001 | CA2393587A1 Use of an immunosuppressant for increasing an antifungal activity of a lipopeptide |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393530A1 Pharmaceutical compositions for oral use |
| 06/14/2001 | CA2393526A1 Nucleic acid delivery system |
| 06/14/2001 | CA2393510A1 New (aminopropyl)methylphosphinic acids |
| 06/14/2001 | CA2393488A1 Use of .alpha.1ar subtype-selective drugs in patients with acute myocardial infarction |
| 06/14/2001 | CA2393470A1 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | CA2393141A1 Novel methods for the treatment and prevention of ileus |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | CA2392568A1 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | CA2392566A1 4-pyridinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
| 06/14/2001 | CA2390859A1 Treatment of inflammatory bowel disease with vitamin d compounds |
| 06/14/2001 | CA2390857A1 Inhibitors of collagen-induced platelet aggregation |
| 06/14/2001 | CA2388959A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 06/14/2001 | CA2388828A1 Topical anesthetic formulation |
| 06/14/2001 | CA2388686A1 Vla-4 integrin antagonists |
| 06/14/2001 | CA2384982A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | CA2362845A1 Eplerenone crystalline form |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2362669A1 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/14/2001 | CA2362606A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | CA2361647A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106612A1 Quinoline derivatives useful for inhibiting farnesyl protein transferase |
| 06/13/2001 | EP1106611A1 Crystalline or crystallized acid addition salt of losartan and purification method of losartan |
| 06/13/2001 | EP1106610A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 06/13/2001 | EP1106608A1 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1106605A1 Alpha1b-adrenergic receptor antagonists |
| 06/13/2001 | EP1106604A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/13/2001 | EP1106599A1 Chromium l-threonate, process for preparation of the same and their use |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1106184A2 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
| 06/13/2001 | EP1106180A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | EP1106178A1 Remedies for multiple sclerosis |
| 06/13/2001 | EP1106177A1 Tumor tissue accumulation enhancers for drugs |
| 06/13/2001 | EP1106176A1 Remedies for renal failure |
| 06/13/2001 | EP1106175A1 Anti-inflammatory analgesics |
| 06/13/2001 | EP1106169A2 Emulsions |
| 06/13/2001 | EP1105728A1 Modulating multiple lineage kinase proteins |
| 06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105513A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105494A2 Drug targets in candida albicans |
| 06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/13/2001 | EP1105462A1 Engraftable human neural stem cells |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105413A2 Hepatitis c inhibitor tri-peptides |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/13/2001 | EP1105407A2 Aminosterol compounds and uses thereof |
| 06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 06/13/2001 | EP1105403A1 3'-desoxypentopyranosyl nucleic acid, its production and its use |
| 06/13/2001 | EP1105401A1 Phosphoglycolipid and methods for its use |
| 06/13/2001 | EP1105395A1 Photocyclized rapamycins |
| 06/13/2001 | EP1105393A1 Bicyclic piperidine and piperazine compounds having 5-ht 6? receptor affinity |
| 06/13/2001 | EP1105391A2 New compounds |
| 06/13/2001 | EP1105390A2 New compounds |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105388A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 06/13/2001 | EP1105387A1 Prodrugs of proton pump inhibitors |
| 06/13/2001 | EP1105386A1 Novel salt form of pantoprazole |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105383A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/13/2001 | EP1105382A2 Method for the preparation of citalopram |
| 06/13/2001 | EP1105381A1 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 06/13/2001 | EP1105379A1 Water soluble analogs and prodrugs of paclitaxel |
| 06/13/2001 | EP1105378A1 Quinazoline derivatives |
| 06/13/2001 | EP1105377A1 Pyrimidinone derivatives for the treatment of atherosclerosis |
| 06/13/2001 | EP1105376A1 Oxindole derivatives as growth hormone releasers |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
| 06/13/2001 | EP1105141A2 Phosphatidylcholine as a medicament for the protection of mucosa |